Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Non Squamous Lung Cancer × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 29 Neoplasms 24 Fatigue 18 Depression 17 Prostatic Neoplasms 12 Lymphoma, Follicular 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Multiple Myeloma 10 Pain 9 Lymphoma, Large B-Cell, Diffuse 9 Lung Neoplasms 9 Colorectal Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Lymphoma, Non-Hodgkin 8 Lymphoma, Mantle-Cell 8 Lymphoma, Large-Cell, Immunoblastic 8 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Myeloid, Chronic-Phase 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Hodgkin Disease 8 Burkitt Lymphoma 8 Vomiting 7 Nausea 7 Leukemia, Hairy Cell 7 Carcinoma, Ovarian Epithelial 7 Lymphoma, T-Cell, Cutaneous 6 Leukemia, Myeloid, Acute 6 Leukemia, Myeloid, Accelerated Phase 6 Head and Neck Neoplasms 6 Blast Crisis 6

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01154140 2017-11-06

PROFILE 1014

Pfizer

Phase 3 Completed

343 enrolled 31 charts

Non Squamous Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡